ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Nashville, TN, USA:

Teplizumab in Pediatric Stage 2 Type 1 Diabetes (PETITE-T1D)

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Sanofi
Sanofi

Nashville, Tennessee, United States and 9 other locations

The central hypothesis is that inflammation mediators are biomarkers of both systemic diabetes and Diabetic Retinopathy (DR) progre...

Active, not recruiting
Diabetic Retinopathy
Drug: Ketorolac 0.45% ophthalmic solution
Drug: Placebo - Preservative-free artificial tears

Phase 1

Stephen J. Kim, MD

Nashville, Tennessee, United States

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Nashville, Tennessee, United States and 40 other locations

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator

Phase 3

Prokidney

Nashville, Tennessee, United States and 96 other locations

study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...

Enrolling
Diabetes, Type 2
Type 2 Diabetes
Drug: PF-08653944
Other: Placebo

Phase 3

Pfizer
Pfizer

Goodlettsville, Tennessee, United States and 183 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Nashville, Tennessee, United States and 29 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Nashville, Tennessee, United States and 228 other locations

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device
Piomic Medical

Nashville, Tennessee, United States and 28 other locations

This study is being done to look at how well a study medicine called CagriSema helps people with diabetes lower their blood sugar. In this s...

Begins enrollment in 4 months
Diabetes Mellitus, Type 2
Drug: Placebo CagriSema
Drug: CagriSema

Phase 2

Novo Nordisk
Novo Nordisk

Nashville, Tennessee, United States and 60 other locations

of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: LY3841136

Phase 2

Lilly
Lilly

Nashville, Tennessee, United States of America and 51 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems